Figure 3.
![Subsequent ACR among participant with first ACR >100 mg/g. The median of the first episode of ACR >100 mg/g was 175.8 (IQR, 135-242), while next ACR was 117.3 (IQR, 64-292). Among the participants 9 (22%) has an increase (median increase, 72% [IQR, 13%-157%] and 32 [78%]) had a decrease (median decrease, 45% [IQR, 13%-74%]) in their susequent ACR.](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/7/22/10.1182_bloodadvances.2023010101/3/blooda_adv-2023-010101-gr3.jpeg?Expires=1735835997&Signature=jQiCSbCrvVDAdd1kgVBfU4N-IiWMWUhtc-qzhGCWPhkoq35lk~jnUK4xnMWJyJoaiW-GXxDaOJ8O8FDSvxy0fmySvGYtEv4Jg0vc76vJlpk2y2wO9tCSaHayVgDE4mydE0E8Ynq3eFKb16xb3848JsvdoWXIFo2FZtvxufcrAr0WMmGgeM3T0J3zHjBuiNfgbLhLllHGt0rPIRq5DH54hEhvjcmVT8RCuQaXwqnXrIUEwspkUxo2ZjzcoTaCAF5CkkBIrmwO6kfjVyFiKiQVuTwEH5B2VNB56XOwKN7yzGj7UvWt97DiHiI5BJugtX0iyfuLIBdYGqYbLM~TbnUikQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Subsequent ACR among participant with first ACR >100 mg/g. The median of the first episode of ACR >100 mg/g was 175.8 (IQR, 135-242), while next ACR was 117.3 (IQR, 64-292). Among the participants 9 (22%) has an increase (median increase, 72% [IQR, 13%-157%] and 32 [78%]) had a decrease (median decrease, 45% [IQR, 13%-74%]) in their susequent ACR.
